An extremely rare case of small-cell lung cancer harboring variant 2 of the EML4-ALK fusion gene

被引:28
|
作者
Toyokawa, Gouji [1 ]
Takenoyama, Mitsuhiro [1 ]
Taguchi, Kenichi [2 ]
Toyozawa, Ryo [1 ]
Inamasu, Eiko [1 ]
Kojo, Miyako [1 ]
Shiraishi, Yoshimasa [1 ]
Morodomi, Yosuke [1 ]
Takenaka, Tomoyoshi [1 ]
Hirai, Fumihiko [1 ]
Yamaguchi, Masafumi [1 ]
Seto, Takashi [1 ]
Shimokawa, Mototsugu [3 ]
Ichinose, Yukito [1 ]
机构
[1] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Minami Ku, Fukuoka 8111395, Japan
[2] Kyushu Natl Canc Ctr, Inst Clin Res, Canc Pathol Lab, Fukuoka 8111395, Japan
[3] Kyushu Natl Canc Ctr, Inst Clin Res, Fukuoka 8111395, Japan
关键词
Small-cell lung cancer; Oncogenic driver mutation; EML4-ALK; MUTATIONS;
D O I
10.1016/j.lungcan.2013.05.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Anaplastic lymphoma kinase (ALK) fuses echinoderm microtubule-associated protein-like 4 (EML4) to acquire a transforming activity in lung adenocarcinomas. However, the presence of an EML4-ALK fusion gene in other lung cancer histologies is an extremely rare phenomenon. A 43-year-old female was referred to our department due to dyspnea on effort and left back pain. Computed tomography (CT) showed a large mass in the upper lobe of the left lung and a massive left pleural effusion, while a CT-guided needle biopsy confirmed a diagnosis of small-cell lung cancer (SCLC). Surprisingly, the tumor was genetically considered to harbor the EML4-ALK fusion gene (variant 2). Although the patient underwent two regimens of cytotoxic chemotherapy for SCLC, she died approximately seven months after the administration of first-line chemotherapy. Our analysis of 30 consecutive patients with SCLC for EML4-ALK revealed that two patients, including the current patient and a patient we previously reported, harbored the EML4-ALK fusion gene. (c) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:487 / 490
页数:4
相关论文
共 50 条
  • [31] Pulmonary Inflammatory Myofibroblastic Tumor Harboring EML4-ALK Fusion Gene
    Sokai, Akihiko
    Enaka, Makiko
    Sokai, Risa
    Mori, Shoichi
    Mori, Shunsuke
    Gunji, Masaharu
    Fujino, Masahiko
    Ito, Masafumi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (01) : 93 - 96
  • [32] Non-small Cell Lung Cancer Patients with EML4-ALK Fusion Gene Are Insensitive to Cytotoxic Chemotherapy
    Morodomi, Yosuke
    Takenoyama, Mitsuhiro
    Inamasu, Eiko
    Toyozawa, Ryo
    Kojo, Miyako
    Toyokawa, Gouji
    Shiraishi, Yoshimasa
    Takenaka, Tomoyoshi
    Hirai, Fumihiko
    Yamaguchi, Masafumi
    Taguchi, Kenichi
    Seto, Takashi
    Sugio, Kenji
    Ichinose, Yukito
    ANTICANCER RESEARCH, 2014, 34 (07) : 3825 - 3830
  • [33] EML4-ALK AND OTHER FUSION KINASES IN LUNG CANCER
    Mano, Hiroyuki
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S438 - S438
  • [34] EML4-ALK Fusion in Lung Reply
    Falini, Brunangelo
    Martelli, Maria Paola
    Pileri, Stefano A.
    Sozzi, Gabriella
    Gasparini, Patrizia
    AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (03): : 1553 - 1554
  • [35] A rare double ALK fusion variant EML4-ALK and CDK15-ALK in lung adenocarcinoma and response to crizotinib A case report
    Guo, Jun
    Shi, Junping
    Yao, Ming
    Jin, Yi
    Liu, Dengxiang
    Liu, Weiling
    Wang, Kai
    Jiang, Da
    MEDICINE, 2020, 99 (45) : E22631
  • [36] CLINICAL CHARACTERISTICS OF PATIENTS WITH NON SMALL-CELL LUNG CANCER HARBORING EGFR MUTATION OR EML4-ALK IN CHINESE HAN ETHNICITY POPULATION
    Li, Aiwu
    Ren, Shengxiang
    Chen, Xiaoxia
    Ni, Jian
    Zhou, Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S468 - S468
  • [37] Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene
    Fukui, Takayuki
    Yatabe, Yasushi
    Kobayashi, Yoshihisa
    Tomizawa, Kenji
    Ito, Simon
    Hatooka, Shunzo
    Matsuo, Keitaro
    Mitsudomi, Tetsuya
    LUNG CANCER, 2012, 77 (02) : 319 - 325
  • [38] EML4-ALK fusion gene expressing transgenic mouse for lung cancer model
    Pyo, Kyoung-Ho
    Kim, Hye Ryun
    Lim, Sun Min
    Yun, Mi Ran
    Kim, Sung-Moo
    Kim, Hwan
    Kang, Han Na
    Lee, Ji Min
    Kim, Sang Gyun
    Cho, Byoung Chul
    CANCER RESEARCH, 2016, 76
  • [39] ANALYSIS OF CLINICOPATHOLOGICAL FEATURES FOR CHINESE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER HARBORING EML4-ALK FUSION GENES
    Shi, Yuankai
    Liu, Yutao
    Hao, Xuezhi
    Wang, Lin
    Han, Xiaohong
    Li, Dan
    Zhou, Yujie
    Tang, Le
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S913 - S914
  • [40] Clinical features and prognostic implications of EML4-ALK fusion gene in resected non-small cell lung cancer
    Ryu, H. S.
    Xu, X.
    Chung, J. -H.
    Lee, H. J.
    VIRCHOWS ARCHIV, 2010, 457 (02) : 188 - 188